Medline (MDLN) Shares Outstanding (Diluted Average) (2025 - 2026)
Medline (MDLN) reported Shares Outstanding (Diluted Average) of $824.8 million for Q1 2026, up 1.87% on a QoQ basis from $809.7 million in Q4 2025.
Medline (MDLN) has 2 years of Shares Outstanding (Diluted Average) data on file, last reported at $824.8 million in Q1 2026.
- Quarterly Shares Outstanding (Diluted Average) changed N/A year-over-year to $824.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $824.8 million (changed N/A YoY) and the FY2025 annual result came in at $809.7 million, changed N/A from the prior year.
- Shares Outstanding (Diluted Average) climbed to $824.8 million in Q1 2026 per MDLN's latest filing, from $809.7 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $824.8 million in Q1 2026 and bottomed at $809.7 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 146.28 Bn | 141.88 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.14 Bn | 40.13 Bn | 2.15 Bn | - |
| 3 | Medline | 29.16 Bn | 35.00 Bn | 1.84 Bn | 824.84 Mn |
| 4 | Resmed | 27.13 Bn | 25.47 Bn | 890.98 Mn | 145.72 Mn |
| 5 | West Pharmaceutical Services | 22.71 Bn | 22.19 Bn | 296.40 Mn | 72.40 Mn |
| 6 | Solventum | 13.26 Bn | 13.26 Bn | 1.10 Bn | 175.50 Mn |
| 7 | Align Technology | 12.22 Bn | 11.16 Bn | 736.59 Mn | 71.61 Mn |
| 8 | Cooper Companies | 11.79 Bn | 11.66 Bn | 695.20 Mn | 196.70 Mn |
| 9 | Baxter International | 9.47 Bn | 7.42 Bn | 891.00 Mn | 515.00 Mn |
| 10 | Aptargroup | 7.19 Bn | 6.99 Bn | 351.91 Mn | 64.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 824.84 Mn |
| Dec 31, 2025 | 809.69 Mn |